Effect of trovafloxacin on production of cytokines by human monocytes

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1713-1717

  Khan, Anis A ^a,b   Slifer, Teri R ^a   Remington, Jack S ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TROVAFLOXACIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOREACTIVITY; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

EID: 0031836426     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1713     Document Type: Article

References (38)

1. Bailly, S., M. Fay, Y. Roche, and M. A. Gougerot-Pocidalo. 1990. Effects of quinolones on tumor necrosis factor production by human monocytes. Int. J. Immunopharmacol. 12:31.
2. Bailly, S., Y. Mahe, B. Ferrua, M. Fay, T. Tursz, H. Wakasugi, and M.-A. Gougerot-Pocidalo. 1990. Quinolone induced differential modification of IL-1α and IL-1ß production by LPS-stimulated human monocytes. Cell. Immunol. 128:277-288.
3. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725.
4. Chin, J., and M. J. Kostura. 1993. Dissociation of IL-1ß synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J. Immunol. 151:5574-5581.
5. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
6. Dinarello, C. A. 1994. The IL-1 family: 10 years of discovery. FASEB J. 8:1314-1325.
7. Fischman, A. J., J. W. Babich, A. A. Bonab, N. M. Alpert, J. Vincent. R. J. Callahan, J. A. Correia, and R. H. Rubin. 1997. Tissue pharmacokinetics of F-18 trovafloxacin in healthy human subjects, abstr. A-68, p. 14. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Gazzinelli, R. T., D. Amichay, T. Sharton-Kersten, E. Grunwald, J. M. Farber, and A. Sher. 1996. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. Curr. Top. Microbiol. Immunol. 219:127-139.
9. Gollapudi, S. V. S., R. H. Prabhala, and H. Thadepalli. 1986. Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation. Antimicrob. Agents Chemother. 29:337-338.
10. Grabstein, K. H., D. L. Urdal, R. J. Tushinski, D. Y. Mochizuki, V. L. Price, M. A. Cantrell, S. Gillis, and P. J. Conlon. 1986. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232:506-508.
11. Hahn, H., B. Wos, and U. Sperling. 1985. Influence of ciprofloxacin on specific interactions on listeria-specific T cells with antigen in vitro, p. 96-103. In D. Adam, H. Hahn, and W. Opferkuch (ed.), The influence of antibiotics on the host-parasite relationship, vol. II. Springer-Verlag, Berlin, Germany.
12. Handman, E., and A. W. Burgess. 1979. Stimulation by granulocyte-macrophage colony stimulating factor of Leishmania tropica killing by macrophages. J. Immunol. 122:1134.
13. Hauser, W. E., Jr., and J. S. Remington. 1982. Effect of antibiotics on the immune response. Am. J. Med. 72:711-716.
14. Hunter, C. A., and J. S. Remington. 1994. Immunopathogenesis of toxoplasmic encephalitis. J. Infect. Dis. 170:1057-1067.
15. Hunter, C. A., Y. Suzuki, C. S. Subauste, and J. S. Remington. 1996. Cells and cytokines in resistance to Toxoplasma gondii. Curr. Top. Microbiol. Immunol. 219:113-125.
16. Iino Y., M. Toriyama, K. Kudo, Y. Natori, and A. Yuo. 1992. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann. Otol. Rhinol. Laryngol. 101:16-20.
17. Kearns, G. L., J. S. Bradley, M. D. Reed, and J. Vincent. 1997. Trovafloxacin (TROV) pharmacokinetics (PK) in infants and children, abstr. A-104, p. 21. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Khan, A. A., T. Slifer, F. G. Araujo, R. J. Polzer, and J. S. Remington. 1997. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Antimicrob. Agents Chemother. 41:893-897.
19. Khan, A. A., T. Slifer, F. G. Araujo, and J. S. Remington. 1996. Trovafloxacin is active against Toxoplasma gondii. Antimicrob. Agents Chemother. 40: 1855-1859.
20. Korzeniowski, O. M. 1989. Effects of antibiotics on the mammalian immune system. Infect. Dis. Clin. N. Am. 3:469-478.
21. Mayer, P., C. Lam, H. Obenaus, E. Liehl, and J. Besemer. 1987. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in non-human primates. Blood 70:206-213.
22. Metcalf, D. 1977. Hematopoietic colonies. In vitro cloning of normal and leukemic cells. Springer-Verlag, Berlin, Germany.
23. Moore, G. W., A. O'Garra, R. de Waal-Malefyt, P. Vieria, and T. Mosman. 1993. Interleukin-10. Annu. Rev. Immunol. 11:167-190.
24. Morikawa, K., F. Oseko, S. Morikawa, and K. Iwamoto. 1994. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. Antimicrob. Agents Chemother. 38:2643-2647.
25. Morikawa, K., H. Watabe, M. Araake, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 40:1366-1370.
26. Riesbeck, K., and A. Forsgren. 1994. Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology 27:155-164.
27. Riesbeck, K., and A. Forsgren. 1994. Limited effects of temafloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob. Agents Chemother. 38:879-882.
28. Riesbeck, K., M. Sigvardsson, T. Leanderson, and A. Forsgren. 1994. Superinduction of cytokine gene transcription by ciprofloxacin. J. Immunol. 153:343-352.
29. Roche, Y., M. Fay, and M.-A. Gougerot-Pocidalo. 1987. Effects of quinolones on interleukin 1 production in vitro by human monocytes. Immunopharmacology 13:99-109.
30. Roche, Y., M.-A. Gougerot-Pocidalo, M. Fay, D. Etienne, N. Forest, and J.-J. Pocidalo. 1987. Comparative effects of quinolones on human mononuclear leucocyte functions. J. Antimicrob. Chemother 19:781-790.
31. Stevens, D. L. 1996. Immune modulatory effects of antibiotics. Curr. Opin. Infect. Dis. 9:165-169.
32. Stunkel, K. G. E., G. Hewlett, and H. J. Zeiler. 1991. Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin. Exp. Immunol. 86:525-531.
33. Takeshita, K., I. Yamagishi, M. Harada, S. Otomo, T. Nakagawa, and Y. Mizushima. 1989. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp. Clin. Res. 15:527-533.
34. Teng, R., S. C. Harris, D. E. Nix, J. J. Schentag, G. Foulds, and T. E. Liston. 1995. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J. Antimicrob. Chemother. 36:385-394.
35. Tocchi, M. J., N. I. Hutchinson, P. M. Cameron, K. E. Kirk, D. J. Norman, J. Chin, E. A. Rupp, G. A. Limjuco, V. M. Bonilla-Argudo, and J. A. Schmidt. 1987. Expression in Escherichia coli and characterization of recombinant human interleukin-1ß: comparison with native IL-1ß. J. Immunol. 138:1109-1114.
36. Tracey, K. J. 1997. Tumor necrosis factor, p. 223-239. In D. G. Remick and J. S. Friedland (ed.), Cytokines in health and disease, 2nd ed. Marcel Dekker, New York, N.Y.
37. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
38. Van Vlem, B., R. Vanholder, P. De Paepe, D. Vogelaers, and S. Ringoir. 1996. Immunomodulating effects of antibiotics: literature review. Infection 24:275-291.